EUVIMEDEUVIMED entdecken
Crossref

Regulation of iron metabolism in radioresistant glioblastoma

Ali, Md Yousuf

Iowa Research Online (The University of Iowa) · 01.01.2024

DOI: 10.25820/etd.006769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Iowa Research Online (The University of Iowa), erschienen am 01.01.2024. Verfasst von Ali und 1 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common and most lethal adult primary malignant brain tumor. Median progression-free and overall survival after initial diagnosis are 6.2-7.5 and 14-20 months, respectively, even with a highly aggressive standard-of-care treatment. One of the main reasons for this poor survival is development of resistance to standard of care therapy, especially, resistance to radiotherapy. Defining the molecular mechanism(s) responsible for the adaptive radioresistance in GBM is necessary for the development of effective treatment options. The cellular labile iron pool (LIP) is very important for determining the cellular response to radiation, as it contributes to radiation-induced production of reactive oxygen species (ROS). Recently, cytochrome c oxidase (CcO), a mitochondrial heme-containing enzyme also involved in regulating ROS production, was found to be involved in GBM chemoresistance. However, the role of LIP and CcO in GBM radioresistance is not known. Herein, we tested the hypothesis that CcO-mediated alterations in the level of LIP contribute to adaptive radioresistance. Using an in vitro model of GBM adaptive radioresistance, we found an increase in CcO activity in radioresistant cells that is associated with a decrease in the cellular LIP, a decrease in lipid peroxidation and a switch in the CcO subunit 4 (COX4) isoform expression, from COX4-2 to COX4-1. We further observed that radioresistant cells have increased expression of mitoferrin-1 (MFRN1), a protein that facilitates the incorporation of iron into mitochondria. Overexpression of MFRN1 in glioma cells increases the activity of mitochondrial protein complexes, a decrease in cellular LIP, and a decrease in production of 4-hydroxy nonenal (4-HNE), a lipid peroxidation product. Furthermore, MFRN1 overexpression also enhances the proliferation rate and anchorage independent growth. Moreover, MFRN1 overexpression significantly decreased survival in an orthotopic mouse model of glioma. These results indicate that manipulation of cellular and mitochondrial iron homeostasis may provide a novel strategy to improve therapeutic outcome in patients with GBM.

Schlagwörter

glioblastomaradioresistance (biology)iron metabolismlabile iron poolcytochrome c oxidasemitochondrial iron homeostasislipid peroxidationreactive oxygen speciestumor cell proliferationorthotopic mouse model

Zitieren

APA

Ali, & Yousuf, M. (2024). Regulation of iron metabolism in radioresistant glioblastoma. Iowa Research Online (The University of Iowa). https://doi.org/10.25820/etd.006769

Vancouver

Ali, Yousuf M. Regulation of iron metabolism in radioresistant glioblastoma. Iowa Research Online (The University of Iowa). 2024. doi:10.25820/etd.006769

BibTeX
@article{Ali2024,
  author = {Ali and Yousuf, Md},
  title = {Regulation of iron metabolism in radioresistant glioblastoma},
  journal = {Iowa Research Online (The University of Iowa)},
  year = {2024},
  doi = {10.25820/etd.006769}
}
Kostenlos starten →